SC8
6 minutes ago
Sorry but 5 patients with metastatic cancer aren't "thriving". I get the initial safety study, albeit apparently flawed per FDA standards if indeed tumors were under dosed, was done on patients that had nothing to lose, but try to be sensitive about their condition. They aren't "thriving".